Myrbetriq 8 mg/mL
mirabegron · GRANULE, FOR SUSPENSION, EXTENDED RELEASE · Astellas Pharma US, Inc.
No Recall History
Plain English
Myrbetriq is a granule, for suspension, extended release containing mirabegron at 8 mg/mL, taken oral. Manufactured by Astellas Pharma US, Inc..
Key Facts
- Brand Name
- Myrbetriq
- Generic Name
- mirabegron
- NDC Code (Product)
0469-5020- Manufacturer
- Astellas Pharma US, Inc.
- Strength
- 8 mg/mL
- Dosage Form
- GRANULE, FOR SUSPENSION, EXTENDED RELEASE
- Route
- ORAL
- Marketing Status
- Application #
- NDA213801
- Drug Class
- beta3-Adrenergic Agonist [EPC]
- Marketing Start
- 03/25/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Myrbetriq used for?
Myrbetriq contains mirabegron. It is a granule, for suspension, extended release taken oral. Consult your doctor for specific uses.
Is Myrbetriq a controlled substance?
Myrbetriq is not classified as a controlled substance by the DEA.
What is the generic name for Myrbetriq?
The generic name for Myrbetriq is mirabegron. There are 11 other brand versions of mirabegron.
What is the NDC code for Myrbetriq 8 mg/mL?
The NDC (National Drug Code) for Myrbetriq 8 mg/mL is 0469-5020, listed by Astellas Pharma US, Inc..